173 related articles for article (PubMed ID: 20597627)
1. Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours.
Yarmolenko PS; Zhao Y; Landon C; Spasojevic I; Yuan F; Needham D; Viglianti BL; Dewhirst MW
Int J Hyperthermia; 2010; 26(5):485-98. PubMed ID: 20597627
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
3. Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome.
Chen Q; Krol A; Wright A; Needham D; Dewhirst MW; Yuan F
Int J Hyperthermia; 2008 Sep; 24(6):475-82. PubMed ID: 18608573
[TBL] [Abstract][Full Text] [Related]
4. Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With
Santos MA; Goertz DE; Hynynen K
Theranostics; 2017; 7(10):2718-2731. PubMed ID: 28819458
[TBL] [Abstract][Full Text] [Related]
5. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome.
Chen Q; Tong S; Dewhirst MW; Yuan F
Mol Cancer Ther; 2004 Oct; 3(10):1311-7. PubMed ID: 15486198
[TBL] [Abstract][Full Text] [Related]
7. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
[TBL] [Abstract][Full Text] [Related]
8. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.
Kim HR; You DG; Park SJ; Choi KS; Um W; Kim JH; Park JH; Kim YS
Mol Pharm; 2016 May; 13(5):1528-39. PubMed ID: 26998616
[TBL] [Abstract][Full Text] [Related]
9. Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes.
Al-Jamal WT; Kostarelos K
Nanotheranostics; 2022; 6(3):230-242. PubMed ID: 35145834
[TBL] [Abstract][Full Text] [Related]
10. Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation.
Gasselhuber A; Dreher MR; Negussie A; Wood BJ; Rattay F; Haemmerich D
Int J Hyperthermia; 2010; 26(5):499-513. PubMed ID: 20377363
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy.
Pereira S; Ma G; Na L; Hudoklin S; Kreft ME; Kostevsek N; Al-Jamal WT
Acta Biomater; 2022 Mar; 140():530-546. PubMed ID: 34954416
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterisation of ultrasound imageable heat-sensitive liposomes for HIFU therapy.
Maples D; McLean K; Sahoo K; Newhardt R; Venkatesan P; Wood B; Ranjan A
Int J Hyperthermia; 2015; 31(6):674-85. PubMed ID: 26185910
[TBL] [Abstract][Full Text] [Related]
13. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia.
Al-Jamal WT; Al-Ahmady ZS; Kostarelos K
Biomaterials; 2012 Jun; 33(18):4608-17. PubMed ID: 22459195
[TBL] [Abstract][Full Text] [Related]
15. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermia-triggered drug delivery from iRGD-modified temperature-sensitive liposomes enhances the anti-tumor efficacy using high intensity focused ultrasound.
Deng Z; Xiao Y; Pan M; Li F; Duan W; Meng L; Liu X; Yan F; Zheng H
J Control Release; 2016 Dec; 243():333-341. PubMed ID: 27984104
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermia sensitization and proton beam triggered liposomal drug release for targeted tumor therapy.
Fernando R; Maples D; Senavirathna LK; Zheng Y; Polf JC; Benton ER; Bartels KE; Piao D; Ranjan A
Pharm Res; 2014 Nov; 31(11):3120-6. PubMed ID: 24852892
[TBL] [Abstract][Full Text] [Related]
19. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635
[TBL] [Abstract][Full Text] [Related]
20. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy.
Tagami T; May JP; Ernsting MJ; Li SD
J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
